Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Use and abuse of dissociative and psychedelic drugs in adolescence
M.L. Shawn Bates, Keith A. Trujillo
Pharmacology Biochemistry and Behavior (2021) Vol. 203, pp. 173129-173129
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Preclinical animal models of mental illnesses to translate findings from the bench to the bedside: Molecular brain mechanisms and peripheral biomarkers associated to early life stress or immune challenges
Nadia Cattane, Anthony C. Vernon, Alessandra Borsini, et al.
European Neuropsychopharmacology (2022) Vol. 58, pp. 55-79
Open Access | Times Cited: 39
Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry
Gregory Barber, Charles C. Dike
Psychiatric Services (2023) Vol. 74, Iss. 8, pp. 838-846
Closed Access | Times Cited: 37
Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study
Grant Jones, Matthew K. Nock
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 28
Brain oxygen responses induced by opioids: focus on heroin, fentanyl, and their adulterants
Eugene A. Kiyatkin, Shinbe Choi
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 6
3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18F-FDG PET/CT Case Report
Maria Pepe, Marco Di Nicola, Fabrizio Cocciolillo, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 452-452
Open Access | Times Cited: 4
Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin Use
David S. Mathai, Daniel E. Roberts, Sandeep M. Nayak, et al.
Journal of Psychoactive Drugs (2025), pp. 1-12
Open Access
Ciências Forenses: Aplicações Científicas na Criminalística
Samara Alves Testoni, Cláudio M. P. Pereira, Rafael Scorsatto Ortiz
Revista Brasileira de Criminalística (2025) Vol. 14, Iss. 1, pp. 77-77
Open Access
Set and setting predict psychopathology, wellbeing and meaningfulness of psychedelic experiences: a correlational study
Lucas F. Borkel, Jaime Rojas-Hernández, Luis Alberto Henríquez‐Hernández, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 17, Iss. 2, pp. 165-176
Closed Access | Times Cited: 12
MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations
Samuli Kangaslampi, Josjan Zijlmans
European Child & Adolescent Psychiatry (2023)
Open Access | Times Cited: 9
Pediatric suicide: Review of a preventable tragedy
Donald E. Greydanus, Ahsan Nazeer, Zheala Qayyum, et al.
Disease-a-Month (2024) Vol. 70, Iss. 9, pp. 101725-101725
Closed Access | Times Cited: 3
Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents
Grant Jones, Diego Arias, Matthew K. Nock
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 15
Potential Therapeutic Effects of Psilocybin: A Systematic Review
Dev B Goel, Sarju Zilate
Cureus (2022)
Open Access | Times Cited: 13
Ketamine Use in Child and Adolescent Psychiatry: Emerging Data in Treatment-Resistant Depression, Insights from Adults, and Future Directions
Kaitlyn Ryan, Avinash Hosanagar
Current Psychiatry Reports (2023) Vol. 25, Iss. 8, pp. 337-344
Closed Access | Times Cited: 7
Therapeutic potential of psychedelics: History, advancements, and unexplored frontiers
Juliana Marino Maia, Bruna Stefane Alves de Oliveira, Luiz G.S. Branco, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 131, pp. 110951-110951
Closed Access | Times Cited: 2
Developmental changes in brain structure and function following exposure to oral LSD during adolescence
Lila Harris-Blum, Zachary M. Smith, Richard J. Ortiz, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?
Antonio Munafò, Davide Arillotta, Guido Mannaioni, et al.
Pharmaceuticals (2022) Vol. 16, Iss. 1, pp. 68-68
Open Access | Times Cited: 10
Acid liberalism: Silicon Valley's enlightened technocrats, and the legalization of psychedelics
Maxim Tvorun‐Dunn
International Journal of Drug Policy (2022) Vol. 110, pp. 103890-103890
Closed Access | Times Cited: 9
BDNF Alterations in Brain Areas and the Neurocircuitry Involved in the Antidepressant Effects of Ketamine in Animal Models, Suggest the Existence of a Primary Circuit of Depression
Ezio Carboni, Anna R. Carta
Journal of Integrative Neuroscience (2022) Vol. 21, Iss. 5
Open Access | Times Cited: 8
Basic metabolic and vascular effects of ketamine and its interaction with fentanyl
Matthew R. Irwin, Carlos M. Curay, Shinbe Choi, et al.
Neuropharmacology (2023) Vol. 228, pp. 109465-109465
Open Access | Times Cited: 4
High doses of dextromethorphan induced shock and convulsions in a 19-year-old female: A case report
Shintaro Shimozawa, Daisuke Usuda, Toru Sasaki, et al.
World Journal of Clinical Cases (2023) Vol. 11, Iss. 16, pp. 3870-3876
Open Access | Times Cited: 4
Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use
Grant Jones, Felipe Herrmann, Erica Wang
Addictive Behaviors Reports (2023) Vol. 18, pp. 100513-100513
Open Access | Times Cited: 4
Dissociation and Temporality in Substance Abuse: A Clinical Phenomenological Overview
Valerio Ricci, Giuseppe Maina, Giovanni Martinotti
Psychopathology (2023) Vol. 57, Iss. 3, pp. 219-228
Closed Access | Times Cited: 4
Psychedelic Drugs or Hallucinogens: Exploring Their Medicinal Potential
P. Deepak Raj, Shyambabu Rauniyar, Bhagyesh Sapkale
Cureus (2023)
Open Access | Times Cited: 4
Implementation fidelity of a Brazilian drug use prevention program and its effect among adolescents: a mixed-methods study
Julia D. Gusmões, Rodrigo García-Cerde, Juliana Y. Valente, et al.
Substance Abuse Treatment Prevention and Policy (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Psychedelic public health: State of the field and implications for equity
Heather Kuiper, Chris Alley, Zoë Harris, et al.
Social Science & Medicine (2024) Vol. 357, pp. 117134-117134
Closed Access
Page 1 - Next Page

Scroll to top